Ethics FORUM Elizabeth A. Kitsis, MD, MBE, Michele Meltzer, MD, MBE, and C. Ronald MacKenzie, MD | January 17, 2011Understanding the challenges in rheumatology today
Immunizations and Autoimmune Disease Vanessa Caceres | December 1, 2010What is safe and what to avoid in this patient population
No Clear Connection Between Inflammation & Disease Progression in AS Kathy Holliman | October 1, 2010TNF blockers decrease symptoms but seem to have little impact on structural damage
Are We Playing It Safe? Anja Strangfeld, MD, and Angela Zink, PhD | October 1, 2010Tumor necrosis factor alpha inhibition and the risk of solid malignancies
TNF Blockade for SLE Martin Aringer, MD, and Maria Dall’Era, MD | September 1, 2010Reckless approach versus missed opportunity?
National Academy of Sciences Elects Three Rheumatologists Kurt Ullman | August 1, 2010First time three people from the specialty selected in the same year
Meet the Model Biologics Policy From the College | July 1, 2010At its February meeting, the ACR board of directors approved the Model Biologics Policy, which will be used when discussing guidelines and patients’ quality of treatment with health insurance companies.
Tracking Patient Manifestations of Behçet’s Syndrome around the World Yusuf Yazici, MD | July 1, 2010Tracking patient manifestations of Behçet’s syndrome around the world